OClawVPS.com
Rapha Capital
Edit

Rapha Capital

https://raphacap.com
Last activity: 26.02.2025
Active
Invests in categories: MedtechHealthTechTechnologyBioTechResearchPlatformProductEngineeringDevelopmentVideo
Portfolio
15
Mentions
6

Portfolio 15

DateNameWebsiteTotal RaisedLocation
-Demeetrademeetra.com-United Sta...
-Poseida Th...poseida.com$282.5MUnited Sta...
-Sightlysightly.com$7.3MUnited Sta...
-IMAGIN Med...imaginmedical.com--
-K2biok2-biolabs.com-United Sta...
-Ponce Ther...poncetherapeutics.com-United Sta...
-FIZE Medic...fizemedical.com$35.3M-
-NuMat Tech...numat.tech-United Sta...
-DELiver Th...deliverthera.com--
-AsclepiX T...asclepix.com$50M-
Show more

Mentions in press and media 6

DateTitleDescription
26.02.2025Eos SENOLYTIX, a Longevity Medicine Company, Announces the Appointment of Brent Saunders as Advisory Board ChairmanEos SENOLTYIX, Inc. • Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 While Botox has become one of the most successful anti-aging pr...
30.08.2021Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.
03.05.2021Rapha Capital Management Launches First Fund Focused on Early-Stage Biotech StartupsRapha Capital Management, a Miami, FL-based investment management firm focused on life sciences, launched its first managed venture capital fund, with a target raise of $100M. Rapha Capital BioVentures Fund I, LP, is solely focused on inves...
16.04.2021Rapha Capital Management launches $100M life science VC fund with an eye on early scienceLife science venture capital firm Rapha Capital Management has launched its first managed venture capital fund with a target raise of $100M and “solely focused” on investment in early-stage life science companies. The money, which is being ...
15.04.2021Rapha Capital Management Announces First Managed Venture Fund Focused on Investment in Early-Stage Biotech Startups
24.02.2021Rapha Capital Management Announces Successful Initial Public Offering of Portfolio Company NexImmune Inc.

Reviews 0

Sign up to leave a review

Sign up Log In